The Miriam Hospital says it has treated the first patients in the world in two new clinical trials testing therapies for prostate cancer, offering local patients access to treatments years before they ...
World Cancer Day collaboration supports clearer, more inclusive access to cancer clinical trials By hosting the ...
New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...
Add Yahoo as a preferred source to see more of our stories on Google. Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to compare ...
A subset of metastatic prostate cancers progress on hormonal therapy to a non–androgen-receptor-dependent phenotype characterized by tumor suppressor loss, neuroendocrine features, and aggressive ...
For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of cancer therapies called RIPTAC™ (Regulated Induced Proximity TArgeting ...
The study's testing accurately identified prostate cancer 91% of the time and accurately ruled out men without prostate cancer 84% of the time. A urine-based biomarker panel may be a promising, ...
The significant reliance on forward-looking statements may create uncertainty about the company's future, as actual outcomes could differ materially from expectations due to various risks and ...
The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results